ArticlePloS one2012
The return on investment of a Medicaid tobacco cessation program in Massachusetts.
Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Return on investment of public health interventions: a systematic review.Journal of epidemiology and community health · 2017Pooled it
- Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program.American journal of preventive medicine · 2024Trial
- Provider-delivered tobacco dependence treatment to Medicaid smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014Trial
- Estimating the return on investment of the New York Tobacco Control Programme: a synthetic control study.BMJ open · 2024Article
- Examining Racial/Ethnic Disparities in Tobacco Dependence Treatment Among Medicaid Beneficiaries Using Fifty State Medicaid Claims, 2009-2014.Journal of racial and ethnic health disparities · 2024Article
- Prescription Smoking-Cessation Medication Fills and Spending, 2009-2019.American journal of preventive medicine · 2022Article
- Policy Recommendations to Eliminate Tobacco Use and Improve Health from the American Thoracic Society Tobacco Action Committee.Annals of the American Thoracic Society · 2022Article
- Rates of Tobacco Use Disorder, Pharmacologic Treatment, and Associated Mental Health Disorders in a Medicaid Claim Review Among Youth in Indiana, USA.Tobacco use insights · 2022Article
- Medicaid coverage for tobacco dependence treatment: Enrollee awareness and use.Preventive medicine reports · 2021Article
- Estimating the return on investment of the Bureau of Tobacco Free Florida tobacco control programme from 1999 to 2015.BMJ open · 2021Article
- Impact of Medicaid expansion on smoking prevalence and quit attempts among those newly eligible, 2011-2019.Tobacco prevention & cessation · 2021Article
- Policy Implementation Science - An Unexplored Strategy to Address Social Determinants of Health.Ethnicity & disease · 2021Article
- State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2008-2018.MMWR. Morbidity and mortality weekly report · 2020Article
- Public insurance expansions and smoking cessation medications.Economic inquiry · 2019Article
- Current advances in research in treatment and recovery: Nicotine addiction.Science advances · 2019Review
- Screening for Lung Cancer Has Limited Effectiveness Globally and Distracts From Much Needed Efforts to Reduce the Critical Worldwide Prevalence of Smoking and Related Morbidity and Mortality.Journal of global oncology · 2018Article
- State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2015-2017.MMWR. Morbidity and mortality weekly report · 2018Article
- A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective.ClinicoEconomics and outcomes research : CEOR · 2018Article
- Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee.Lancet (London, England) · 2017Review
- Barriers to Utilizing Medicaid Smoking Cessation Benefits.Kansas journal of medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveA high proportion of low-income people insured by the Medicaid program smoke. Earlier research concerning a comprehensive tobacco cessation program implemented by the state of Massachusetts indicated that it was successful in reducing smoking prevalence and those who received tobacco cessation benefits had lower rates of in-patient admissions for cardiovascular conditions, including acute myocardial infarction, coronary atherosclerosis and non-specific chest pain. This study estimates the costs of the tobacco cessation benefit and the short-term Medicaid savings attributable to the aversion of inpatient hospitalization for cardiovascular conditions.
methodsA cost-benefit analysis approach was used to estimate the program's return on investment. Administrative data were used to compute annual cost per participant. Data from the 2002-2008 Medical Expenditure Panel Survey and from the Behavioral Risk Factor Surveillance Surveys were used to estimate the costs of hospital inpatient admissions by Medicaid smokers. These were combined with earlier estimates of the rate of reduction in cardiovascular hospital admissions attributable to the tobacco cessation program to calculate the return on investment.
findingsAdministrative data indicated that program costs including pharmacotherapy, counseling and outreach costs about $183 per program participant (2010 $). We estimated inpatient savings per participant of $571 (range $549 to $583). Every $1 in program costs was associated with $3.12 (range $3.00 to $3.25) in medical savings, for a $2.12 (range $2.00 to $2.25) return on investment to the Medicaid program for every dollar spent.
conclusionsThese results suggest that an investment in comprehensive tobacco cessation services may result in substantial savings for Medicaid programs. Further federal and state policy actions to promote and cover comprehensive tobacco cessation services in Medicaid may be a cost-effective approach to improve health outcomes for low-income populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.